Lung auscultation showed discrete crepitation of the lower right lung.
Laboratory findings were a mild leukocytosis and C-reactive protein increase.
Chest radiograph (AP-view) ( Fig. 1 ) shows a normal cardiac size and bilateral, predominantly perihilar, areas of increased opacity.
High-resolution CT examination of the lungs (Fig. 2 ) revealed multifocal ground glass attenuation with areas of consolidation and discrete peribronchovascular thickening, here depicted on an axial image (A). A Reformatted image in the coronal plane (B) shows the diffuse extent in both lungs. There was a normal heart size and no presence of pleural effusion.
Based on the clinical and CT findings the diagnosis of pulmonary hemorrhage was made. The presence of hemoptysis, hypoxemia, recent amphetamine use and rapid radiographic recovery supported the diagnosis. of intra-alveolar red blood cells originating from the alveolar capillaries. The classical clinical triad includes hemoptysis, anemia and hypoxemia, which can be severe (1).
On plain radiography DAH manifests as multifocal bilateral areas of increased opacity with a normal heart size. High-resolution CT shows multifocal ground-glass attenuation, which occasionally is centrilobular in distribution and associated with inter lobular septal thickening.
The differential diagnosis of these radiologic findings must be broad and include acute lung injury, diffuse infection, and noninfectious inflammatory conditions (e.g. pulmonary hemorrhage and acute hypersensitivity pneumonitis).
Inhaled and intravenously abused drugs, including opiates and cocaine after oral amphetamine intake published. Our patient provided us with an experience of uncomplicated DAH after the oral use of MDMA (ecstasy) that resolved under supportive care without significant sequelae. MDMA-induced acute pulmonary edema in a patient without other organ dysfunction. Am J Emerg Med, 2006, 24: 734-736. been widely investigated. Observational studies in humans and direct animal experiments had demonstrated typical acute toxic syndromes, including hyperthermia, hyponatremia, myocardial ischemia, intracerebral hemorrhage, acute hepatic failure and acute hallucinogenic psychosis (3). Although there are a few case reports of MDMA-related acute noncardiogenic pulmonary edema to be found in the literature (4), limited work has been done concerning the pulmonary toxic effects of MDMA. The mechanism causing noncardiogenic pulmonary edema due to abuse of amphetamines, a structurally similar material with MDMA, is still not clear but may be due to direct cellular toxicity as suggested by animal studies (4).
To our knowledge there hasn't been a single case report of MDMAinduced diffuse alveolar hemorrhage or crack, are known to cause acute lung injury (noncardiogenic pulmonary edema) and DAH. The mechanism by which the increased pulmonary capillary permeability occurs in acute lung injury is unclear, but is thought to be the consequence of a pulmonary endothelial abnormality (2).
Diffuse alveolar hemorrhage and acute lung injury are radiographically indistinguishable. Because of this the development of respiratory failure with bilateral airspace consolidation that typically appear shortly after crack use and rapid recovery after the cessation of the responsible agent had been termed "crack lung". Lung biopsy of this condition has revealed diffuse alveolar damage, alveolar hemorrhage, and interstitial and intra-alveolar inflammatory cell infiltration (3).
During the past 2 decades, the acute toxic effects of MDMA have A Fig. 2 . -High-resolution CT reveals multifocal ground glass attenuation with areas of consolidation and discrete peribronchovascular thickening (A). Reformatted image in the coronal plane (B) shows the diffuse extent in both lungs.
